AI Proteins and Astellas Sign $400 Million Drug Discovery Deal
AI Proteins has signed a research collaboration and licensing agreement with Astellas Pharma to discover and develop new miniprotein-based medicines using artificial intelligence (AI).…
Read More...
Read More...
